Abstract
Abnormalities of molecules associated with the glutamate synapse have been implicated in the pathophysiology of schizophrenia. Of the many glutamate receptors, those most commonly suggested to be involved in schizophrenia are the ionotropic subtypes, the NMDA, AMPA, and kainate receptors. Both the NMDA and AMPA subtypes have been extensively studied in postmortem brains of individuals with schizophrenia, but relatively little is known about the expression of the kainate subtype of glutamate receptor. In this study, we have determined cortical and striatal kainate receptor expression in brains from persons with schizophrenia and a comparison group, using both in situ hybridization and receptor autoradiography. At the level of subunit mRNA expression, a shift in subunit stoichiometry was evident in multiple regions of the prefrontal cortex, with increased expression of gluR7 mRNA and decreased expression of KA2 mRNA. Decreased kainate receptor binding was also observed in the subjects with schizophrenia, but was restricted to infragranular laminae of the prefrontal cortex. No differences in kainate receptor binding or subunit mRNA levels were found in striatum or occipital cortex, suggesting that these findings may be restricted to association cortex. These data add to the growing literature implicating ionotropic glutamate receptor disturbances in schizophrenia, and indicate that in addition to AMPA and NMDA receptors, the kainate receptors are also abnormally expressed in this illness.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Breese CR, Freedman R, Leonard S . (1995): Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers. Brain Res 674: 82–90
Carlsson M, Carlsson A . (1990): Schizophrenia: A subcortical neurotransmitter imbalance syndrome? Schizophrenia Bulletin 16: 425–432
Deakin JFW, Slater P, Simpson MDC, Gilchrist AC, Skan AC, Royston MC, Reynolds GP, Cross AJ . (1989): Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia. J Neurochem 52: 1781–1786
Eastwood SL, Porter RHP, Harrison PJ . (1996): The effect of chronic haloperidol on glutamate receptor subunit (gluR1, gluR2, KA1, KA2, NR1) mRNAs and glutamate binding protein mRNA in rat forebrain. Neurosci Lett 212: 163–166
Egebjerg J, Bettler B, Hermans-Borgmeyer I, Heinemann S . (1991): Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA. Nature 351: 745–748
Goff DC, Tsai G, Manoach DS, Coyle JT . (1995): Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia. Am J Psychiatry 152: 1213–1215
Goff DC, Tsai G, Manoach DS, Coyle JT . (1999): A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry 56: 21–27
Healy DJ, Haroutunian V, Powchik P, Davidson M, Davis KL, Watson SJ, Meador-Woodruff JH . (1998): AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics. Neuropsychopharmacology 19: 278–286
Healy DJ, Meador-Woodruff JH . (1997): Clozapine and haloperidol differentially affect AMPA and kainate receptor subunit mRNA levels in rat cortex and striatum. Mol Brain Res 47: 331–338
Heresco-Levy U, Javitt DC, Ermilov M, Mordel C, Silipo G, Lichtenstein M . (1999): Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Arch Gen Psychiatry 56: 29–36
Hollmann M, Heinemann S . (1994): Cloned glutamate receptors. Annu Rev Neurosci 17: 31–108
Itil T, Keskiner A, Kiremitci N, Holden JMC . (1967): Effect of phencyclidine in chronic schizophrenia. Can J Psychiatry 12: 209–212
Javitt DC, Zukin SR . (1991): Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148: 1301–1308
Javitt DC, Zylberman I, Zukin SR, Heresco-Levy U, Lindenmayer JP . (1994): Amelioration of negative symptoms in schizophrenia by glycine. Am J Psychiatry 151: 1234–1236
Kerwin R, Patel S, Meldrum B . (1990): Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem. Neuroscience 39: 25–32
Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB, Charney DS . (1994): Subanesthetic effects of the noncompetitive NMDA antagonist ketamine in humans: Psychotomimetic perceptual cognitive and neuroendocrine responses. Arch Gen Psychiatry 51: 199–214
Lahti AC, Holcomb HH, Medoff DR, Tamminga CA . (1995): Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport 6: 869–872
Lerma J . (1998): Kainate receptors: an interplay between excitatory and inhibitory synapses. FEBS Lett 430: 100–104
Luby E, Gottlieb J, Cohen B, Rosenbaum G, Domino E . (1962): Model psychoses and schizophrenia. Am J Psychiatry 119: 61–67
Meador-Woodruff JH, Haroutunian V, Powchik P, Davidson M, Davis KL, Watson SJ . (1997): Dopamine receptor transcript expression in striatum prefrontal and occipital cortex: focal abnormalities in orbitofrontal cortex in schizophrenia. Arch Gen Psychiatry 54: 1089–1095
Meador-Woodruff JH, Healy DJ . (2000): Glutamate receptor expression in schizophrenic brain. Brain Res Reviews 31: 288–294
Nishikawa T, Takashima M, Toru M . (1983): Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia. Neurosci Lett 40: 245–250
Noga JT, Hyde TM, Herman MM, Spurney CF, Bigelow LB, Weinberger DR, Kleinman JE . (1997): Glutamate receptors in the postmortem striatum of schizophrenic, suicide, and control brains. Synapse 27: 168–176
Nutt SL, Kamboj R . (1994): RNA editing of human kainate receptor subunits. NeuroReport 5: 2625–2629
Paschen W, Hedreen JC, Ross CA . (1994): RNA editing of the glutamate receptor subunits gluR2 and gluR6 in human brain tissue. J Neurochem 63: 1596–1602
Porter RHP, Eastwood SL, Harrison . (1997): Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal gluR6 and KA2 transcripts in schizophrenia. Brain Res 751: 217–231
Schiffer JJ, Swanson GT, Heinemann SF . (1997): Rat gluR7 and a carboxy-terminal splice variant, gluR7b, are functional kainate receptor subunits with a low sensitivity to glutamate. Neuron 19: 1141–1146
Seeburg PH . (1996): The role of RNA editing in controlling glutamate receptor channel properties. J Neurochem 66: 1–5
Sokolov BP . (1998): Expression of NMDAR1, gluR1, gluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of “neuroleptic free” schizophrenics: Evidence on reversible up-regulation by typical neuroleptics. J Neurochem 71: 2454–2464
Swanson GT, Feldmeyer D, Kaneda M, Cull-Candy SG . (1996): Effect of RNA editing and subunit co-assembly on single-channel properties of recombinant kainate receptors. J Physiol 492: 129–142
Tarazi F, Florijn WJ, Creese I . (1996): Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics. Psychopharmacology 128: 371–379
Wilding TJ, Heuttner JE . (1997): Activation and desensitization of hippocampal kainate receptors. J Neurosci 17: 2713–2721
Acknowledgements
This work was supported by MH53327 (JHMW), a Veterans Administration Merit Review Award (VH), and MH45212, AG5138, and AG2219 (KLD). The authors gratefully acknowledge the expert technical assistance of Alan Hogg. Daniel J. Healy, M.D., and Oren Cahlon assisted in earlier versions of this work. A preliminary version of this work was presented at the annual meeting of the Society of Biological Psychiatry, Toronto, Ontario, Canada, May, 1998.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Meador-Woodruff, J., Davis, K. & Haroutunian, V. Abnormal Kainate Receptor Expression in Prefrontal Cortex in Schizophrenia. Neuropsychopharmacol 24, 545–552 (2001). https://doi.org/10.1016/S0893-133X(00)00189-5
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1016/S0893-133X(00)00189-5
Keywords
This article is cited by
-
Intrathecal Injection of GRIP-siRNA Reduces Postoperative Synaptic Abundance of Kainate Receptor GluK2 Subunits in Rat Dorsal Horns and Pain Hypersensitivity
Neurochemical Research (2021)
-
Lamina-Specific Abnormalities of NMDA Receptor-Associated Postsynaptic Protein Transcripts in the Prefrontal Cortex in Schizophrenia and Bipolar Disorder
Neuropsychopharmacology (2008)
-
An association analysis of synapse-associated protein 97 (SAP97) gene in schizophrenia
Journal of Neural Transmission (2008)
-
Cytogenetic and genetic evidence supports a role for the kainate-type glutamate receptor gene, GRIK4, in schizophrenia and bipolar disorder
Molecular Psychiatry (2006)
